Bio-Rad Laboratories Inc financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$1.09B $1.18B $1.27B $1.46B $1.76B $1.78B $1.93B $2.07B $2.07B $2.13B $2.18B $2.02B $2.07B $2.16B $2.29B $2.31B $2.55B $2.92B $2.80B $2.67B $0.00M
GM % Gross Margin %
55.97% 54.74% 55.93% 54.16% 54.55% 56.04% 56.64% 56.85% 55.83% 55.26% 54.45% 55.54% 55.15% 55.08% 53.66% 54.57% 56.41% 56.91% 55.97% 53.42% 0.00%
OM Operating Margin
11.33% 9.76% 11.79% 9.78% 12.00% 13.16% 14.74% 14.72% 11.99% 7.67% 7.13% 8.26% 7.20% 7.05% 8.52% 10.94% 16.06% 19.33% 17.38% 12.65% 0.00%
EPS Earnings Per Share
$3.44 $3.53 $3.79 $4.30 $5.33 $6.21 $6.26 $5.80 $3.90 $4.17 $3.85 $2.64 $3.82 $5.84 $7.06 $10.52 $15.66 $14.42 $11.54 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0.00% 0.00% 0 0 0 0 0.00% 0.00% 0 0 0 0 0 0 0.00% 0.00% 0.00% 0.00% 0.00% 0
Sha. Shares
25.81m 26.17m 26.48m 26.85m 27.29m 27.48m 27.8m 28.12m 28.37m 28.69m 28.96m 29.31m 29.54m 29.76m 29.96m 29.93m 29.65m 29.76m 29.7m 0m 29.15m
OCF Operating Cash Flow
$123.10M $108.28M $118.23M $191.58M $191.37M $325.07M $225.91M $262.74M $266.48M $169.14M $273.31M $186.21M $216.07M $104.14M $285.49M $457.90M $575.33M $669.50M $194.40M $374.94M $0.00M
FCF Free Cash Flow
$62.61M $72.22M $65.24M $-196.09M $106.56M $258.27M $138.65M $156.93M $126.48M $62.48M $152.31M $74.21M $75.00M $-7.45M $155.67M $359.37M $476.41M $535.72M $93.70M $424.08M $0.00M
FCFS Free Cash Flow Per Share
$2.05 $2.58 $2.47 $4.83 $3.78 $9.03 $4.82 $5.69 $4.31 $2.16 $4.74 $2.50 $2.53 $-0.37 $5.22 $12.34 $16.12 $17.96 $2.69 $12.84 $0.00